Home » Topics » Disease categories and therapies » Urology

Urology
RSS

YM-178: a selective beta3-adrenoceptor agonist for the treatment of overactive bladder

April 24, 2007

Anturol absorbed on bioequivalent basis from three application sites

April 23, 2007

First phase II study under way for cetrorelix for BPH

April 23, 2007

Uritos approved for overactive bladder in Japan

April 19, 2007

Renvela meets primary endpoint in hyperphosphatemic patients

April 18, 2007

sanofi-aventis reports novel therapeutic agents for renal disorders

April 13, 2007

Ditropan to be reviewed by FDA

April 13, 2007

Recent Inotek patent reports new agents for treating urinary incontinence

April 11, 2007

Recent Tokai University and Sankyo patent covers new therapeutic agents for renal disorders

April 10, 2007

PRX-302 begins phase I study for BPH

April 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...